Report Code : CVMI2501125 | Published Date : March 3, 2025

The Global Infectious Disease Therapeutics Market is undergoing a paradigm shift, fueled by emerging antimicrobial resistance patterns, pandemic preparedness initiatives, and breakthrough therapeutic modalities. Valued at USD 125.4 billion in 2023, the market is projected to grow at a CAGR of 6.8%, reaching USD 212.9 billion by 2031. This comprehensive analysis examines the complex interplay of scientific innovation, public health priorities, and market forces reshaping treatment landscapes for bacterial, viral, fungal, and parasitic infections.

The COVID-19 pandemic served as a watershed moment, exposing critical gaps in therapeutic arsenals while accelerating regulatory pathways for novel antimicrobials. This report provides a detailed evaluation of therapeutic class performance, pipeline developments, and geographic demand patterns across hospital and community settings. Special attention is given to the growing threat of antimicrobial resistance (AMR), which the WHO estimates could cause 10 million annual deaths by 2050 without intervention, and the corresponding push for novel antibiotic development through public-private partnerships.

2. Market Overview

2.1 Market Definition & Scope

The infectious disease therapeutics market encompasses pharmaceutical interventions for:

  • Bacterial Infections (XX% market share)
    • Community-acquired pneumonia
    • Drug-resistant tuberculosis
    • Complicated UTIs
    • MRSA infections
  • Viral Infections (XX%)
    • HIV/AIDS
    • Hepatitis B/C
    • Influenza
    • Emerging viral threats
  • Fungal Infections (XX%)
  • Parasitic Diseases (8%)

Key product categories:

  • Small Molecule Antibiotics (XX%)
  • Antivirals (XX%)
  • Biologics & Immunotherapies (15%)
  • Other Therapeutics (XX%)

2.2 Market Size & Forecast (2023-2031)

  • 2023 Market Size: USD 125.4 Billion
  • 2031 Projected Size: USD 212.9 Billion
  • CAGR: 6.8%
  • Therapeutic Courses: 35 billion (2023) → 52 billion (2031)

2.3 Key Market Segments

By Drug Class:

  1. Antibiotics (XX% share)
    • Beta-lactams (XX%)
    • Fluoroquinolones (XX%)
    • Macrolides (XX%)
    • Novel AMR drugs (30%)
  2. Antivirals (XX%)
    • HIV antiretrovirals (XX%)
    • Direct-acting antivirals (XX%)
    • Broad-spectrum (XX%)
    • Other (10%)
  3. Antifungals (XX%)
  4. Antiparasitics (8%)

By Distribution Channel:

  • Hospital Pharmacies (55%)
  • Retail Pharmacies (XX%)
  • Online Pharmacies (XX%)

By Region:

  • North America (40%)
  • Europe (XX%)
  • Asia-Pacific (XX%)
  • Rest of World (XX%)

3. Market Dynamics

3.1 Market Drivers

1. Antimicrobial Resistance Crisis

  • 1.27 million deaths annually attributed to AMR
  • WHO priority pathogen list driving R&D investment
  • 10x increase in public funding since 2015

2. Pandemic Preparedness

  • USD 30 billion committed globally for countermeasures
  • Accelerated approval pathways for novel antivirals

3. Therapeutic Advancements

  • Phage therapy entering phase III trials
  • CRISPR-based antimicrobials in development
  • Monoclonal antibodies for viral infections

4. Emerging Market Demand

  • 25% growth in tropical disease therapeutics
  • Universal healthcare expansion increasing access

3.2 Market Challenges

1. Antibiotic Development Economics

  • USD 1.5 billion average development cost
  • Limited ROI due to stewardship requirements

2. Pricing & Reimbursement Pressures

  • 50% price erosion for generics in developing markets
  • HTA restrictions on premium-priced novel agents

3. Diagnostic Gaps

  • 60% empiric treatment without pathogen ID
  • Slow adoption of rapid diagnostics

3.3 Market Trends

1. Precision Antimicrobials

  • Pathogen-targeted narrow spectrum drugs
  • Biomarker-guided therapy duration

2. Combination Therapies

  • Antibiotic-adjuvant combinations
  • Multidrug regimens for resistant infections

3. Subscription Models

  • Netflix-style antibiotic payment models
  • Pull incentives for AMR drug development

4. Competitive Landscape

4.1 Market Share Analysis

Company

Market Share

Key Products

Strategic Focus

Pfizer

15%

Prevnar, Zavicefta

AMR portfolio expansion

Gilead

12%

Biktarvy, Veklury

Antiviral leadership

Merck

10%

Keytruda, Dificid

Immuno-infectious pipeline

GSK

8%

Juluca, Tivicay

HIV franchise dominance

Novartis

7%

Cosentyx, Entresto

Anti-infective biologics

4.2 Emerging Players

  • Nabriva: Novel pleuromutilin antibiotics (45% growth)
  • Atea Pharma: Broad-spectrum antivirals
  • Armata: Clinical-stage phage therapies

4.3 Recent Developments (2024)

  • Pfizer acquired AMR biotech for USD 6.7 billion
  • Gilead launched pan-coronavirus antiviral
  • Merck received breakthrough designation for novel TB drug

5. Regional Analysis

5.1 North America (XX%)

  • US dominates with 85% regional share
  • CARB-X funding driving antibiotic innovation

5.2 Europe (XX%)

  • UK leading AMR national action plan
  • EU Joint Action on antimicrobial consumption

5.3 Asia-Pacific (28%)

  • China fastest-growing at 9% CAGR
  • India AMR containment efforts

6. Future Outlook

6.1 Short-Term Projections (2025)

  • 5+ novel antibiotics receiving FDA approval
  • Subscription models adopted in 3+ countries

6.2 Medium-Term Outlook (2027)

  • Phage therapy commercial launches
  • AI-designed antimicrobials entering trials

6.3 Long-Term Forecast (2031)

  • 30% market share for precision antimicrobials
  • Global AMR treaty implementation




Reasons To Buy

Image



Scope

Image

Key Players

Global Infectious Disease Therapeutics Market Report

Global Infectious Disease Therapeutics Market Report

  1. 1. Global Infectious Disease Therapeutics Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Infectious Disease Therapeutics Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Infectious Disease Therapeutics Market Research Report - Preface
    1. 2.1 Global Infectious Disease Therapeutics Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Disease Type
      2. 2.1.2 By Drug Type
      3. 2.1.3 By End-user
      4. 2.1.4 By Region
    3. Global Infectious Disease Therapeutics Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Disease Type, By Drug Type, By End-user, By Country
    3. 3.3. Opportunities – By Disease Type, By Drug Type, By End-user, By Country
    4. 3.4. Trends – By Disease Type, By Drug Type, By End-user, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Infectious Disease Therapeutics Market Research Report – DROTs Impact Analysis
    4. Global Infectious Disease Therapeutics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Infectious Disease Therapeutics Market, By Disease Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Bacterial Infections
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Viral Infections
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Fungal Infections
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 5.4 Parasitic Infections
      1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Infectious Disease Therapeutics Market, By Drug Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Antibiotics
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Antivirals
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Antifungals
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 6.4 Antiprotozoals
      1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 6.5 Others
      1. 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Infectious Disease Therapeutics Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Hospitals
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Clinics
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Research Institutes
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 7.4 Homecare.
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Infectious Disease Therapeutics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 8.5 Middle East & Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 8.6 Global Infectious Disease Therapeutics Market - Opportunity Analysis Index, By Disease Type, By Drug Type, By End-user, and Region, 2024 - 2031
    9. North America Infectious Disease Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Bacterial Infections
      2. 9.1.2 Viral Infections
      3. 9.1.3 Fungal Infections
      4. 9.1.4 Parasitic Infections
      9.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Antibiotics
      2. 9.2.2 Antivirals
      3. 9.2.3 Antifungals
      4. 9.2.4 Antiprotozoals
      5. 9.2.5 Others
      9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Hospitals
      2. 9.3.2 Clinics
      3. 9.3.3 Research Institutes
      4. 9.3.4 Homecare.
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
      9.5 North America Global Infectious Disease Therapeutics Market – Opportunity Analysis Index, By Disease Type, By Drug Type, By End-user, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 North America Global Infectious Disease Therapeutics Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Infectious Disease Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Bacterial Infections
      2. 10.1.2 Viral Infections
      3. 10.1.3 Fungal Infections
      4. 10.1.4 Parasitic Infections
      10.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Antibiotics
      2. 10.2.2 Antivirals
      3. 10.2.3 Antifungals
      4. 10.2.4 Antiprotozoals
      5. 10.2.5 Others
      10.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Hospitals
      2. 10.3.2 Clinics
      3. 10.3.3 Research Institutes
      4. 10.3.4 Homecare.
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands
      8. 10.4.8 Poland
      9. 10.4.9 Rest of Europe
      10.5 Europe Global Infectious Disease Therapeutics Market – Opportunity Analysis Index, By Disease Type, By Drug Type, By End-user, and Country, 2024 - 2031
      10.6 Regional Trends Analysis
      10.7 Europe Global Infectious Disease Therapeutics Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Infectious Disease Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Bacterial Infections
      2. 11.1.2 Viral Infections
      3. 11.1.3 Fungal Infections
      4. 11.1.4 Parasitic Infections
      11.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Antibiotics
      2. 11.2.2 Antivirals
      3. 11.2.3 Antifungals
      4. 11.2.4 Antiprotozoals
      5. 11.2.5 Others
      11.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Hospitals
      2. 11.3.2 Clinics
      3. 11.3.3 Research Institutes
      4. 11.3.4 Homecare.
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & NZ
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
      11.5 Asia-Pacific Global Infectious Disease Therapeutics Market – Opportunity Analysis Index, By Disease Type, By Drug Type, By End-user, and Country, 2024 - 2031
      11.6 Regional Trends Analysis
      11.7 Asia-Pacific Global Infectious Disease Therapeutics Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Infectious Disease Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Bacterial Infections
      2. 12.1.2 Viral Infections
      3. 12.1.3 Fungal Infections
      4. 12.1.4 Parasitic Infections
      12.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Antibiotics
      2. 12.2.2 Antivirals
      3. 12.2.3 Antifungals
      4. 12.2.4 Antiprotozoals
      5. 12.2.5 Others
      12.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Hospitals
      2. 12.3.2 Clinics
      3. 12.3.3 Research Institutes
      4. 12.3.4 Homecare.
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
      12.5 Latin America Global Infectious Disease Therapeutics Market – Opportunity Analysis Index, By Disease Type, By Drug Type, By End-user, and Country, 2024 - 2031
      12.6 Regional Trends Analysis
      12.7 Latin America Global Infectious Disease Therapeutics Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East & Africa Infectious Disease Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Disease Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Bacterial Infections
      2. 13.1.2 Viral Infections
      3. 13.1.3 Fungal Infections
      4. 13.1.4 Parasitic Infections
      13.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Antibiotics
      2. 13.2.2 Antivirals
      3. 13.2.3 Antifungals
      4. 13.2.4 Antiprotozoals
      5. 13.2.5 Others
      13.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Hospitals
      2. 13.3.2 Clinics
      3. 13.3.3 Research Institutes
      4. 13.3.4 Homecare.
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
      13.5 Middle East & Africa Global Infectious Disease Therapeutics Market – Opportunity Analysis Index, By Disease Type, By Drug Type, By End-user, and Country, 2024 - 2031
      13.6 Regional Trends Analysis
      13.7 Middle East & Africa Global Infectious Disease Therapeutics Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
      14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Gilead Sciences Inc.
      2. 14.2.2 GlaxoSmithKline plc
      3. 14.2.3 Merck & Co. Inc.
      4. 14.2.4 Pfizer Inc.
      5. 14.2.5 Johnson & Johnson
    15. Data Collection Method and Research Approach
    16. Principal Presumptions and Acronyms